Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities
Net income (loss)	$ (802)	$ 12,951
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization (including amortization of deferred financing costs and fair value of debt)	5,056	3,403
Amortization of lease intangibles	3,120	2,054
Straight-line rental income	717	(177)
Loan discount accretion	(1,205)	(716)
Discount accretion received in cash	5,865
Earnings of preferred equity investments	(7)	(202)
Distributions of income from preferred equity investments		94
Income of equity investments	(6,194)	(7,869)
Distributions of income from equity investments	3,926	7,822
Restricted cash held in escrows	(516)	1,509
(Gain) loss on sale of securities carried at fair value	(2)	102
Unrealized gain on securities carried at fair value		(1,718)
Gain on sale of real estate investments	(4,425)	(2,775)
Impairment loss on investments in real estate	9,200
Tenant leasing costs	(1,294)	(156)
Equity compensation expenses	414	43
Bad debt (recovery) expense	(351)	84
Changes in assets and liabilities:
Interest receivable	187	184
Accounts receivable and other assets	227	(903)
Accounts payable, accrued liabilities and other liabilities	(1,250)	(4,546)
Net cash provided by operating activities	12,666	9,184
Cash flows from investing activities
Issuance of loans receivable	(17,492)	(21,437)
Investments in real estate	(1,814)	(396)
Investment in equity investments	(40,002)	(13)
Return of capital distribution from equity investments	418	669
Purchase of securities carried at fair value	(73)
Proceeds from sale of investments in real estate	5,324	11,425
Proceeds from sale of equity investments	200	26
Proceeds from sale of securities carried at fair value	75	9,090
Proceeds from sale of loans receivable	37,052	19,318
Restricted cash held in escrows	1,040	716
Collection of loans receivable	3,214	24,287
Cash from consolidation of properties	332	473
Net cash (used in) provided by investing activities	(11,726)	44,158
Cash flows from financing activities
Principal payments of mortgage loans payable	(2,450)	(1,643)
Payment of secured financing		(10,117)
Restricted cash held in escrows	(2,872)	(2,797)
Deferred financing costs		(228)
Purchase of non-controlling interests		(75)
Contribution from non-controlling interest	149	535
Distribution to non-controlling interest	(20)
Proceeds from issuance of Common Shares under Dividend Reinvestment Plan	91	115
Dividend paid on Common Shares	(5,819)	(5,366)
Dividend paid on Restricted Shares	(19)
Net cash used in financing activities	(10,940)	(19,576)
Net increase (decrease) in cash and cash equivalents	(10,000)	33,766
Cash and cash equivalents at beginning of period	112,512	97,682
Cash and cash equivalents at end of period	102,512	131,448
Supplemental Disclosure of Cash Flow Information
Interest paid	6,672	5,897
Capitalized interest	975
Taxes paid	11	68
Supplemental Disclosure on Non-Cash Investing and Financing Activities
Dividends accrued on Common Shares and Restricted Shares	5,916	5,367
Dividends accrued on Series D Preferred Shares	2,787	2,787
Capital expenditures accrued	2,403	4,117
Conveyance of secured financing in settlement of loans receivable	(29,150)
Forgiveness of loan receivable	190
Seller financing receivable	4,500
Fair value of assets acquired	69,140	62,208
Fair value of liabilities assumed	$ 52,687	$ 62,198